Target-dependent T-cell Activation by Coligation With a PSMA×CD3 Diabody Induces Lysis of Prostate Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Target-dependent T-cell Activation by Coligation With a PSMA×CD3 Diabody Induces Lysis of Prostate Cancer Cells

Published:2009-07 Issue:6 Volume:32 Page:565-573
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Bühler Patrick,Molnar Eszter,Dopfer Elaine P.,Wolf Philipp,Gierschner Dorothee,Wetterauer Ulrich,Schamel Wolfgang W.A.,Elsässer-Beile Ursula

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. Immunologic mechanisms of antitumor activity;Foss;Semin Oncol,2002

2. Challenges and prospects of immunotherapy as cancer treatment;Rescigno;Biochim Biophys Acta,2007

3. T-cell antigen-receptor stoichiometry: pre-clustering for sensitivity;Alarcon;EMBO Rep,2006

4. An evolutionary and structural perspective on T cell antigen receptor function;Malissen;Immunol Rev,2003

5. Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation;Gil;Cell,2002

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Prostate Cancer Using Bispecific T-Cell Engagers against Prostate-Specific Membrane Antigen;ACS Pharmacology & Translational Science;2023-10-06

2. Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies;Cancers;2022-11-21

3. The role of single-nucleotide polymorphisms of the 8q24 chromosome region in patients with concomitant bladder and prostate cancer;Scandinavian Journal of Urology;2022-03-04

4. Enabling the next steps in cancer immunotherapy: from antibody-based bispecifics to multispecifics, with an evolving role for bioconjugation chemistry;RSC Chemical Biology;2022

5. T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity;Pharmaceuticals;2021-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3